Cargando…
Cloperastine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by suppressing mitochondrial oxidative phosphorylation
Esophageal squamous cell carcinoma (ESCC) is a major type of esophageal cancer. The prognosis of patients with ESCC remains poor because of the high morbidity and mortality of the disease. One strategy for drug discovery for ESCC treatment or prevention is screening FDA-approved drugs. In the presen...
Autores principales: | Li, Bo, Yu, Yin, Jiang, Yanan, Zhao, Lili, Li, Ang, Li, Mingzhu, Yuan, Baoyin, Lu, Jing, Dong, Ziming, Zhao, Jimin, Liu, Kangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257628/ https://www.ncbi.nlm.nih.gov/pubmed/34226508 http://dx.doi.org/10.1038/s41420-021-00509-w |
Ejemplares similares
-
Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
por: Zhao, Lili, et al.
Publicado: (2022) -
Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway
por: Wu, Xiangyu, et al.
Publicado: (2021) -
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1
por: Liu, Xinning, et al.
Publicado: (2023) -
Pharmacological and clinical overview of cloperastine in treatment of cough
por: Catania, Maria Antonietta, et al.
Publicado: (2011) -
Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
por: Wei, Yaxing, et al.
Publicado: (2021)